{
 "context": "The following article called '5 Top Stocks Retreat Into Buy Range. Should You Buy?' was published on 2015-08-08. The body of the article is as follows:\n    \nBest Mutual Funds 2015: July Performance Report IBD's new buys list showed the country's leading stock mutual funds the past three months have continued to gobble up top-rated medical stocks, such as Allergan (NYSE:AGN), Celgene (NASDAQ:CELG), Regeneron Pharmaceuticals (NASDAQ:REGN), Molina ... 08/04/2015 06:51 PM ET Big Cap Leaders Sail Past Earnings Season \nWhile earnings reports have hammered some leading stocks, that hasn't been the case for most Big Cap 20 members. With most of the quarterly reports out of the way, the big capitalization leaders have sailed past earnings announcements. Most beat Wall Street's expectations. Also, most have climbed ... 08/03/2015 06:48 PM ET More Pharma Buyouts Ahead? 3 Top Stocks In Buy Range \nMedical stocks continue to show healthy action, both in the U.S. and abroad. But those based outside the states might have the upper hand. Six of the top 10 companies by Composite Rating in the ethical drugmakers group are headquartered outside the United States. The group is ranked No. 6 among ... 08/03/2015 06:21 PM ET Stock Indexes End Flat To Down, Though Small Caps, IBD 50 Rise \nStock indexes traded in a narrow range Friday, posting small losses in mixed volume. The S&P 500 fell 0.2%, while the Nasdaq was flat. The IBD 50 and the small-cap S&P 600 took a more positive path, adding 0.6% and 0.5%, respectively. Volume rose on the NYSE but fell on the Nasdaq. For the ... 07/31/2015 06:42 PM ET 5 Top Stocks Riding Earnings Season To Big Gains \nEarnings season has been unkind to a number of recent leaders like Taser International (NASDAQ:TASR), but it has spurred plenty of other stocks to breakouts or big gains. The market uptrend is still under pressure, but these stocks aren't letting that get in their way. The IBD 50 index rose 0.4% ... 07/31/2015 06:21 PM ET Top Growth Stock Apogee Shows Pick Up In Profit Gains \nLeading building products stock Apogee Enterprises (NASDAQ:APOG) is working on a possible new base amid accelerating earnings growth. The maker of glass walls and windows for commercial buildings has been bumping up against resistance at its 50-day moving average. The stock will need to climb above ... 08/06/2015 05:58 PM ET Top Stock Essent Near Record High Ahead Of Earnings \nEssent (NYSE:ESNT), a provider of mortgage insurance, is showing bullish action after retaking a buy point nearly two months ago in heavy volume. The stock is about 12% past the 26.12 entry, putting it out of buying range. But it's been trading in tight fashion, shaping a three-weeks-tight pattern ... 08/05/2015 05:45 PM ET Two Airlines Near Buy Points After Surging Q2 Profits \nAirlines were the top performing group Monday as oil prices slumped more than 4%. And while a few former leaders like Southwest (NYSE:LUV) and Spirit Airlines (NASDAQ:SAVE) have gotten into trouble, the group still ranks a respectable No. 24 in Tuesday's paper. SkyWest (NASDAQ:SKYW), new to the ... 08/04/2015 05:49 PM ET Two Growth Leaders Set Up, But Time To Be Cautious? \nGray Television's (NYSE:GTN) recent chart action has caused some heartache for investors. The stock is rebounding, and back near a 16.77 buy point after triggering a sell signal last week. Investors who bought at the breakout watched the stock climb 8% past the buy point before a sharp pullback ... 08/03/2015 06:09 PM ET Top Data Center Operator Near High After Q2 Results \nEquinix (NASDAQ:EQIX) is in buy range past a 274.23 buy point from a shallow cup pattern.Shares broke out July 24 in just average trade, but climbed for five straight sessions. The stock's RS line hit a new high as it broke out, helping confirm the move. The base was early-stage after a big reset ... 07/31/2015 05:20 PM ET\n\n    The day before the article was published, the stock price of Regeneron Pharmaceuticals, Inc. was 579.0399780273438 and the day after the article was published, the stock price of Regeneron Pharmaceuticals, Inc. was ",
 "expected": "566.989990234375",
 "date": "2015-08-08",
 "ticker": "REGN",
 "company": "Regeneron Pharmaceuticals, Inc."
}